Advanced hybrid silica nanoparticles with pH-responsive diblock copolymer brushes: optimized design for controlled doxorubicin loading and release in cancer therapy
Open Access
- 14 March 2024
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (13) , 8819-8828
Abstract
This study delves into the development, characterization, and application of modified mesoporous silica nanoparticles (MSNs) for targeted drug delivery in cancer therapy. MSNs were functionalized with poly(2-(diisopropylamino)ethyl methacrylate) (PDPA) and poly(glycidyl methacrylate) (PGMA), and further modified with cross-linkers DAE and Ornithine. Characterization using FT-IR, SEM, TEM, DLS, and XPS confirmed the successful surface modifications, revealing particle sizes primarily within the 63–94 nm range. The MSNs demonstrated a pH-responsive behavior, crucial for smart drug delivery. Loading and release studies using Doxorubicin (DOX) showed a controlled release, with an 8 μg mg−1 loading capacity. Cytotoxicity assays on Caco2 colon cancer cells revealed that unloaded nano-systems, at concentrations above 45 μM, resulted in approximately 60% cell death, indicating inherent anti-cancer properties. However, variations in cytotoxic effects were observed in drug-loaded MSNs, with some modifications showing reduced anti-cancer activity. These findings highlight the potential of MSNs in drug delivery and cancer treatment, emphasizing the importance of nanoparticle design in therapeutic efficacy.Keywords
Funding Information
- King Saud University (RSP2024R238)
This publication has 36 references indexed in Scilit:
- pH‐responsive polymers for drug delivery: Trends and opportunitiesJournal of Polymer Science, 2023
- Can histamine cause an enhancement of the cellular uptake and cytotoxicity of doxorubicin-loaded polylactide nanoparticles?European Journal of Pharmaceutical Sciences, 2023
- Nanomaterials and nanotechnology for biomedical soft robotsMaterials Today Advances, 2022
- The feasibility of oral targeted drug delivery: Gut immune to particulates?Acta Pharmaceutica Sinica B, 2022
- Advances of nanoparticles as drug delivery systems for disease diagnosis and treatmentChinese Chemical Letters, 2022
- Polymethylmethacrylate derivatives Eudragit E100 and L100: Interactions and complexation with surfactantsPolymers for Advanced Technologies, 2020
- Crosslinking Biopolymers for Advanced Drug Delivery and Tissue Engineering Applications2018
- Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapyActa Biomaterialia, 2013
- Polymer Brushes: Promises and ChallengesChemistry – An Asian Journal, 2013
- Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubesBiomaterials, 2009